Literature DB >> 25287320

Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome.

Kirsty Mann1, Jill Magee, Marine Guillaud-Bataille, Christophe Blondel, Brigitte Bressac-de Paillerets, Josie Yeatman, Ingrid Winship.   

Abstract

Medulloblastoma tumours may arise sporadically or as part of an inherited syndrome. A subset of children with medulloblastoma carry germline and somatic mutations in the SUFU tumour suppressor gene located at 10q24. We report a 55 year old woman referred for investigation on the basis of skin lesions and a family history of two children from different unions with medulloblastoma. Examination of our patient revealed facial papules (classified as benign folliculosebaceous hamartomatous lesions) and dysmorphology (macrocephaly, hypertelorism and prognathism). She reported her father and her son share the same dermatological features; photographs of the son display hypertelorism. Sequencing in our patient revealed a splice-site mutation in intron 6 of SUFU (c. 756+1G>A), predicted to lead to skipping of exon 6. We suggest that the emerging phenotype in SUFU associated with familial medulloblastoma may include hamartomatous skin lesions. Consideration of these features, along with macrocephaly will alert clinicians to the likely genetic basis of the syndrome, affording the opportunity for genetic counselling, prenatal or pre-implantation genetic diagnosis in at-risk families.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25287320     DOI: 10.1007/s10689-014-9752-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  15 in total

1.  Identification of a SUFU germline mutation in a family with Gorlin syndrome.

Authors:  L Pastorino; P Ghiorzo; S Nasti; L Battistuzzi; R Cusano; C Marzocchi; M L Garrè; M Clementi; G Bianchi Scarrà
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

2.  Loss of Trp53 promotes medulloblastoma development but not skin tumorigenesis in Sufu heterozygous mutant mice.

Authors:  Karin Heby-Henricson; Asa Bergström; Björn Rozell; Rune Toftgård; Stephan Teglund
Journal:  Mol Carcinog       Date:  2011-08-31       Impact factor: 4.784

3.  Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.

Authors:  Chihiro Kijima; Toshiyuki Miyashita; Maiko Suzuki; Hidehiro Oka; Kiyotaka Fujii
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

4.  Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.

Authors:  J R Toro; G Glenn; P Duray; T Darling; G Weirich; B Zbar; M Linehan; M L Turner
Journal:  Arch Dermatol       Date:  1999-10

5.  Retrospective family study of childhood medulloblastoma.

Authors:  David Ng; Theodora Stavrou; Ling Liu; Michael D Taylor; Bert Gold; Michael Dean; Michael J Kelley; Elizabeth C Dubovsky; Gilbert Vezina; H S Nicholson; Julianne Byrne; James T Rutka; David Hogg; Gregory H Reaman; Alisa M Goldstein
Journal:  Am J Med Genet A       Date:  2005-05-01       Impact factor: 2.802

Review 6.  Lessons from the skin--cutaneous features of familial cancer.

Authors:  Ingrid M Winship; Tracy E Dudding
Journal:  Lancet Oncol       Date:  2008-05       Impact factor: 41.316

7.  Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations.

Authors:  Laurence Brugières; Gaëlle Pierron; Agnès Chompret; Brigitte Bressac-de Paillerets; Federico Di Rocco; Pascale Varlet; Alain Pierre-Kahn; Olivier Caron; Jacques Grill; Olivier Delattre
Journal:  J Med Genet       Date:  2009-10-14       Impact factor: 6.318

8.  Loss of SUFU function in familial multiple meningioma.

Authors:  Mervi Aavikko; Song-Ping Li; Silva Saarinen; Pia Alhopuro; Eevi Kaasinen; Ekaterina Morgunova; Yilong Li; Kari Vesanen; Miriam J Smith; D Gareth R Evans; Minna Pöyhönen; Anne Kiuru; Anssi Auvinen; Lauri A Aaltonen; Jussi Taipale; Pia Vahteristo
Journal:  Am J Hum Genet       Date:  2012-09-07       Impact factor: 11.025

Review 9.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

Review 10.  The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma.

Authors:  D G Evans; P A Farndon; L D Burnell; H R Gattamaneni; J M Birch
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more
  6 in total

1.  Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.

Authors:  Léa Guerrini-Rousseau; Christelle Dufour; Pascale Varlet; Julien Masliah-Planchon; Franck Bourdeaut; Marine Guillaud-Bataille; Rachid Abbas; Anne-Isabelle Bertozzi; Fanny Fouyssac; Sophie Huybrechts; Stéphanie Puget; Brigitte Bressac-De Paillerets; Olivier Caron; Nicolas Sevenet; Marina Dimaria; Sophie Villebasse; Olivier Delattre; Dominique Valteau-Couanet; Jacques Grill; Laurence Brugières
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

2.  Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same.

Authors:  A J Huq; M Walsh; B Rajagopalan; M Finlay; A H Trainer; F Bonnet; N Sevenet; I M Winship
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

3.  A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome).

Authors:  B J A Verkouteren; B Cosgun; M G H C Reinders; P A W K Kessler; R J Vermeulen; M Klaassens; S Lambrechts; J R van Rheenen; M van Geel; M Vreeburg; K Mosterd
Journal:  Br J Dermatol       Date:  2021-11-08       Impact factor: 11.113

Review 4.  Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway.

Authors:  Dengliang Huang; Yiting Wang; Jiabin Tang; Shiwen Luo
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

5.  SUFU haploinsufficiency causes a recognisable neurodevelopmental phenotype at the mild end of the Joubert syndrome spectrum.

Authors:  Valentina Serpieri; Fulvio D'Abrusco; Jennifer C Dempsey; Yong-Han Hank Cheng; Filippo Arrigoni; Janice Baker; Roberta Battini; Enrico Silvio Bertini; Renato Borgatti; Angela K Christman; Cynthia Curry; Stefano D'Arrigo; Joel Fluss; Michael Freilinger; Simone Gana; Gisele E Ishak; Vincenzo Leuzzi; Hailey Loucks; Filippo Manti; Nancy Mendelsohn; Laura Merlini; Caitlin V Miller; Ansar Muhammad; Sara Nuovo; Romina Romaniello; Wolfgang Schmidt; Sabrina Signorini; Sabrina Siliquini; Krzysztof Szczałuba; Gessica Vasco; Meredith Wilson; Ginevra Zanni; Eugen Boltshauser; Dan Doherty; Enza Maria Valente
Journal:  J Med Genet       Date:  2021-10-21       Impact factor: 5.941

6.  Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG).

Authors:  L Guerrini-Rousseau; M J Smith; C P Kratz; B Doergeloh; S Hirsch; S M J Hopman; M Jorgensen; M Kuhlen; O Michaeli; T Milde; V Ridola; A Russo; H Salvador; N Waespe; B Claret; L Brugieres; D G Evans
Journal:  Fam Cancer       Date:  2021-04-16       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.